Literature DB >> 22269837

[State of the art: new developments in cardiac imaging].

José F Forteza Albertí1, José J Gómez de Diego, Ricardo Vivancos Delgado, Jaume Candell Riera, Río Aguilar Torres.   

Abstract

Cardiac imaging continues to reveal new anatomical and functional insights into heart disease. In echocardiography, both transesophageal and transthoracic three-dimensional imaging have been fully developed and optimized, and the value of the techniques that have increased our understanding of cardiac mechanics and ventricular function is well established. At the same time, the healthcare industry has released new devices onto the market which, although they are easier to use, have limitations that restrict their use for routine assessment. Tomography's diagnostic and prognostic value in coronary artery disease continues to increase while radiation exposure becomes progressively lower. With cardiac magnetic resonance imaging, myocardial injury and recovery in ischemic heart disease and following acute coronary syndrome can be monitored in exquisite detail. The emergence of new combined tomographic and gamma camera techniques, exclusively developed for nuclear cardiology, have improved the quality of investigations and reduced radiation exposure. The hybrid or fusion images produced by combining different techniques, such as nuclear cardiology techniques and tomography, promise an exciting future.
Copyright © 2012 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22269837     DOI: 10.1016/j.recesp.2011.11.015

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  1 in total

1.  QUANTITATIVE PLANAR AND VOLUMETRIC CARDIAC MEASUREMENTS USING 64 MDCT AND 3T MRI VS. STANDARD 2D AND M-MODE ECHOCARDIOGRAPHY: DOES ANESTHETIC PROTOCOL MATTER?

Authors:  Randi Drees; Rebecca A Johnson; Rebecca L Stepien; Alejandro Munoz Del Rio; Jimmy H Saunders; Christopher J François
Journal:  Vet Radiol Ultrasound       Date:  2015-06-16       Impact factor: 1.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.